Prognostic Evaluation Based on Dual-Time 18 F-FDG PET/CT Radiomics Features in Patients with Locally Advanced Pancreatic Cancer Treated by Stereotactic Body Radiation Therapy

• Published in: Journal of oncology 2022, Vol.2022, p.6528865
• Main Authors: Wang, Fei, Cheng, Chao, Ren, Shengnan, Wu, Zhongyi, Wang, Tao, Yang, Xiaodong, Zuo, Changjing, Yan, Zhuangzhi, Liu, Zhaobang
• Format: Article
• Language: English
• ISSN: 1687-8450; 1687-8450
• DOI: 10.1155/2022/6528865

F-FDG PET/CT is widely used in the prognosis evaluation of tumor patients. The radiomics features can provide additional information for clinical prognostic assessment. Purpose is to explore the prognostic value of radiomics features from dual-time F-FDG PET/CT images for locally advanced pancreatic cancer (LAPC) patients treated with stereotactic body radiation therapy (SBRT). This retrospective study included 70 LAPC patients who received early and delayed F-FDG PET/CT scans before SBRT treatment. A total of 1188 quantitative imaging features were extracted from dual-time PET/CT images. To avoid overfitting, the univariate analysis and elastic net were used to obtain a sparse set of image features that were applied to develop a radiomics score (Rad-score). Then, the Harrell consistency index (C-index) was used to evaluate the prognosis model. The Rad-score from dual-time images contains six features, including intensity histogram, morphological, and texture features. In the validation cohort, the univariate analysis showed that the Rad-score was the independent prognostic factor ( < 0.001, hazard ratio [HR]: 3.2). And in the multivariate analysis, the Rad-score was the only prognostic factor ( < 0.01, HR: 4.1) that was significantly associated with the overall survival (OS) of patients. In addition, according to cross-validation, the C-index of the prognosis model based on the Rad-score from dual-time images is better than the early and delayed images (0.720 vs. 0.683 vs. 0.583). The Rad-score based on dual-time F-FDG PET/CT images is a promising noninvasive method with better prognostic value.